CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED

Autres langues China Shineway Pharmaceutical Group Limited

Actions

2877

KYG2110P1000

Produits pharmaceutiques

Marché Fermé - Hong Kong S.E. 10:08:28 28/09/2026			Varia. 5j.	Varia. 1 janv.
8,480 ^HKD	+1,19%		+4,56%	-1,40%

27/08	China Shineway Pharmaceutical Group Limited publie ses résultats pour le semestre clos le 30 juin 2026	CI
27/08	China Shineway Pharmaceutical Group Limited annonce un second acompte sur dividende au titre de l'exercice 2026, payable le 25 septembre 2026	CI

Autres langues

27/08	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026
27/08	China Shineway Pharmaceutical Group Limited Declares Second Interim Dividend in Respect of the Fiscal Year Ended December 31, 2026, Payable on 25 September 2026
07/05	China Shineway Pharmaceutical's Turnover Slides 18% in Q1
07/05	China Shineway Pharmaceutical posts Q1 turnover of RMB624 mln
07/05	China Shineway Pharmaceutical Group Limited Reports Unaudited Turnover Results for the First Quarter Ended 31 March 2026
27/03	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025
27/03	China Shineway Pharmaceutical declares 2026 first interim dividend RMB43 cents per share
27/03	China Shineway Pharma's Profit Climbs 13% in 2025
27/03	China Shineway Pharmaceutical Group Limited Approves Dividend for First Interim Dividend in Respect of the Fiscal Year Ending 31 December 2026, Payable on May 19, 2026
07/11	China Shineway Nine-month Revenue Drops 16%
07/11	China Shineway Pharmaceutical Group Limited Announces Turnover Results for the Nine Months Ended 30 September 2025
27/08/25	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2025
27/08/25	China Shineway Pharmaceutical Posts Lower H1 Profit
27/08/25	China Shineway Pharmaceutical Group Limited Announces Second Interim Dividend in Respect of the Fiscal Year Ending December 31, 2025, Payable on September 26, 2025
10/06/25	China Shineway Pharmaceutical Group Limited Appoints Wang Guihua as Member of the Nomination Committee, Effective June 10, 2025
28/03/25	Shineway Pharmaceutical's 2024 Profit Slides 13%; Shares Fall 8%
28/03/25	China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
28/03/25	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2024
28/03/25	China Shineway Pharmaceutical Group Limited Declares First Interim Dividend for the Year Ending 31 December 2025, Payable on May 20, 2025
08/11/24	China Shineway Pharmaceutical Logs 17% Decline in Q1-Q3 Turnover
29/08/24	China Shineway Pharmaceutical Posts About 28% Higher H1 Profit
29/08/24	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2024
29/08/24	China Shineway Pharmaceutical Group Limited Announces Second Interim Dividend in Respect of the Fiscal Year Ending December 31, 2024, Payable on September 27, 2024
29/03/24	China Shineway Pharmaceutical Group Grows 2023 Profit, Declares Interim 2024 Dividend
28/03/24	China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023